Patent directory · USPTO A61K / A61P
Patents matching “formulation”
865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12053444
Therapeutic compounds, formulations, and uses thereof
granted -
US 12054758
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12048691
High dosage tebipenem pivoxil tablet formulation
granted -
US 12049652
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12042558
Method and formulation for improving roflumilast skin penetration lag time
granted -
US 12042479
Use of topical formulations of cannabinoids in the treatment of epidermolysis bullosa and related connective tissue disorders
granted -
US 12036280
High concentration protein formulation
granted -
US 12037618
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12017989
Controlled release pharmaceutical formulations
granted -
US 12016929
Lipid formulations for delivery of therapeutic agents
granted -
US 12016848
Roflumilast formulations with an improved pharmacokinetic profile
granted -
US 12018298
PH20 polypeptide variants, formulations and uses thereof
granted -
US 12011437
Roflumilast formulations with an improved pharmacokinetic profile
granted -
US 12005052
Topical roflumilast formulation having improved delivery and plasma half-life
granted -
US 12005060
Ophthalmic formulations of methotrexate
granted -
US 12005051
Topical roflumilast formulation having improved delivery and plasma half life
granted -
US 12005061
Ophthalmic formulations of methotrexate
granted -
US 12005139
Ophthalmic formulations and related methods
granted -
US 11998604
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11998639
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 11992530
Therapeutic uses for sodium thiosulfate and formulations
granted -
US 11969501
Auris formulations for treating otic diseases and conditions
granted -
US 11964018
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11964047
Ophthalmic formulations and related methods
granted